These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 87214

  • 1. Cancer of the prostate: early diagnosis by zinc and hormone analysis?
    Habib FK, Mason MK, Smith PH, Stitch SR.
    Br J Cancer; 1979 Jun; 39(6):700-4. PubMed ID: 87214
    [Abstract] [Full Text] [Related]

  • 2. Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels.
    Habib FK, Goodman CM, Buck C.
    Urol Res; 1992 Jun; 20(4):281-4. PubMed ID: 1380746
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Endogenous androgen levels of human prostatic tissues].
    Morioka M, Takeda K, Mitsuhata N, Ohashi T, Ohmori H, Saito T, Kanbegawa A.
    Nihon Naibunpi Gakkai Zasshi; 1982 Jul 20; 58(7):876-85. PubMed ID: 6182032
    [Abstract] [Full Text] [Related]

  • 8. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
    Forti G, Salerno R, Moneti G, Zoppi S, Fiorelli G, Marinoni T, Natali A, Costantini A, Serio M, Martini L.
    J Clin Endocrinol Metab; 1989 Feb 20; 68(2):461-8. PubMed ID: 2465302
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hormone-dependency of the human prostate].
    Robel P.
    Bull Cancer; 1986 Feb 20; 73(1):19-22. PubMed ID: 2430651
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.
    Titus MA, Schell MJ, Lih FB, Tomer KB, Mohler JL.
    Clin Cancer Res; 2005 Jul 01; 11(13):4653-7. PubMed ID: 16000557
    [Abstract] [Full Text] [Related]

  • 15. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy.
    Geller J, Albert JD, Nachtsheim DA, Loza D.
    J Urol; 1984 Oct 01; 132(4):693-6. PubMed ID: 6471215
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
    Siiteri PK, Wilson JD.
    J Clin Invest; 1970 Sep 01; 49(9):1737-45. PubMed ID: 4194768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM, Vis AN, van Moorselaar RJ, Bui HN, Blankenstein MA, Meuleman EJ, Heijboer AC.
    BJU Int; 2012 Jan 01; 109(2):176-82. PubMed ID: 21992222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.